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Large Scale Matrix Degradation by Stromal Cells Independent of Invadopodia
Abstract
Invadopodia are actin-rich structures at the base of many neoplastic cells that sequester matrix
metalloproteases that act to degrade the surrounding stroma to facilitate the invasive process.
Conventional invadopodia are dependent upon Src kinase and the large GTPase dynamin 2 (Dyn 2).
Whether invadopodia are the only mechanism by which cells degrade matrix is unclear. We have observed
that cells of mesenchymal origin degrade matrix in an unique way different from tumor cells. The
HYPOTHESIS of this study is that fibroblasts, and other cells of mesenchymal origin, degrade matrix by a
mechanism distinct from that of epithelial-based tumor cells. The CONCLUSION is that stromal cells
degrade matrix by a novel mechanism distinct from traditional invadopodia.
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Figure 1. Tumor Cells and Stromal Cells Exhibit Distinct

Background and Goals

Patterns of Matrix Degradation

Figure 2. Reduction of Dynamin 2 (Dyn 2 ) Induces a
Differential Response in Matrix Degradation Between
Fibroblasts and Epithelial Cells

Figure 3. Tamoxifen-Induced Knockout of Dyn 2 in
MEFs Induces a Substantial Increase of Matrix
Degradation Compared to Controls

a
Invadopodia are actin-rich structures at the base of many neoplastic cells that
sequester matrix metalloproteases that act to degrade the surrounding stroma
to facilitate the invasive process. Conventional invadopodia are dependent upon
Src kinase and the large GTPase dynamin 2 (Dyn 2). Whether invadopodia are
the only mechanism by which cells degrade matrix is unclear. We have observed
that cells of mesenchymal origin degrade matrix in an unique way different from
tumor cells.
The HYPOTHESIS of this study is that fibroblasts, and other cells of
mesenchymal origin, degrade matrix by a mechanism distinct from that
of epithelial-based tumor cells.
The GOALS of this study were to define the mechanisms supporting
this novel form of matrix remodeling by:
- Defining the requirements of Dyn 2 and Src kinase in matrix degradation by
fibroblasts and tumors of epithelial origin.
- Testing the role of Dyn 2 depletion on MT1-MMP accumulation by cells both
internally and at the plasma membrane.

Figure 4. A Reduction of Dyn 2 Causes Accumulation
of MT1-MMP

A variety of different tumor and mesenchymal cell types plated on fluorescent gelatin and
cultured for 8h prior to fixation. (a,b) The pancreatic tumor cells BxPC3 and DanG show
largely invadopodial-like (white arrowheads) and focal adhesion-like (arrows) degradation
patterns. (c) The fibrosarcoma cell line HT1080 exhibits focal adhesion-like degradations and
a unique pattern of centrally positioned degradation structure in a labyrinth or reticular-like
display. (d-f) Mesenchymal cells exhibit a unique pattern of matrix degradation, whether they
be rat fibroblasts, human fibroblasts, or pancreatic stellate cells. (g) Graph depicting the
percentage of each cell type that degrades matrix after 8 hours.

c

Figure 5. Knockdown of Dyn 2 Induces a Modest
Retention of MT1-MMP on the Cell Surface
Assessing the effects of Dyn2 knockdown on matrix degradation in six different fibroblast
and epithelial cell types. Cells were treated with siRNA to reduce Dyn2 levels over 72 h, then
trypsinized, resuspended, and plated on fluorescent gelatin-coated coverslips for six hours
in the presence of the protease inhibitor BB94. Cells were then rinsed and allowed to degrade
for 8 hrs prior to fixation. (a-e) A variety of mesenchymal fibroblastic cells that normally
exhibit modest amounts of degradation show increased matrix remodeling by 4-5-fold upon
reduction of Dyn 2. While some focal adhesion-like degradation (white arrows) is observed,
most of it is a reticular-like degradative pattern at the center of the cell. In contrast,
pancreatic epithelial tumor cells that spontaneously degrade via invadopodia are markedly
inhibited in their degradative capacity by Dyn2 knockdown (g-i). (j) Western blot analysis of
cell homogenates showing near complete elimination of Dyn2 expression in the six cell types
examined.

Figure 6. Matrix Degradation by Epithelial Cells and
Fibroblasts Exhibits Distinct Requirements for Src Kinase

To examine another fibroblast cell line from a Dyn 2 genetic knockout model (kindly
provided by Ferguson and De Camilli, Yale), matrix degradation was analyzed in MEFs
from these knockout mice in the presence and absence of tamoxifen. (a,b) Immunostaining
of control or tamoxifen-treated cells (4-5 days) stained for Dyn 2, or revealing matrix
degradation on a fluorescent gelatin substrate. Control cells show substantial amounts of
endogenous cytoplasmic Dyn 2 but exhibit almost no matrix degradation. In contrast, cells
in which Dyn 2 has been reduced exhibit a 6-7-fold increase in matrix degradation with a
characteristic reticular network pattern. (d) Western blot analysis of cells +/- tamoxifen
treatment blotted for Dyn 2. (e-g) Re-expression of either Dyn 1 or Dyn 2 in tamoxifeninduced Dyn 2 knockout MEFs results in a reversal of the degradation phenotype (reduced
degradation). Fluorescence images showing re-expression of either of the neuronal-specific
Dyn 1 or ubiquitously expressed Dyn 2 with corresponding degradation patterns on
fluorescent gelatin. Note that the surrounding cells in which dynamin is not expressed
degrade large amounts of matrix in comparison to the rescued cells (*) that degrade no
matrix at all. (g) Quantitation of the effect of dynamin knockout on matrix degradation
by MEFs. Note the substantial increase in the tamoxifen-treated Dyn KO cells, which is
markedly reduced by expression of wild type Dyn 2 and Dyn 1-GFP. In contrast, the
Dyn 2K44A mutant-expressing cells continue to degrade large amounts of matrix.

Summary
In this study we have found that:
• Fibroblasts and cells of mesenchymal origin degrade matrix but appear
to do so by a mechanism distinct from epithelial-based tumor cells.
• Matrix degradation in fibroblasts appears to be mediated by focal
adhesion sites or at a reticular structure at the cell base. Epithelial
tumor cells degrade by both focal adhesions and traditional invadopodia.
• Matrix degradation by invadopodia in epithelial tumor cells is markedly
reduced by Dyn2 knockdown or inhibition of Src kinase while degradation
by fibroblasts is increased substantially by Dyn 2 depletion and is Src
independent.

Western blot analysis of six different mesenchymal and epithelial cell lines in which
endogenous Dyn 2 levels have been experimentally reduced, followed by SDS-PAGE
and Western blot analysis with antibodies to MT1-MMP. (b) Quantitation of three
distinct experiments shows a modest accumulation of MT1-MMP protein upon Dyn 2
knockdown. While levels were increased by nearly 50% in the RF, DKO MEFS, and
BxPC3 cells, there was only a modest incease observed in the PSC cells and an actual
loss of protease in the DanG cells.

(a,c) Western blot analysis of cell homogenates of either rat fibroblasts treated with
siRNA to knockdown dynamin, or MEFs treated with tamoxifen to induce the Dyn 2 knockout.
Following reduction of Dyn 2 levels, cells were incubated in biotin to label all cell surface
proteins, then homogenized followed by a pull-down with streptavidin beads, then SDS-PAGE
and Western blot (see cartoon for experimental sequence). (b,d) Graphs represent
quantitation of three different experiments showing both total, and surface populations of
MT1-MMP from cells both before and after Dyn2 knockdown. As shown before in Fig. 4, total
MT1 levels were increased by 2 fold, although changes in the levels of MT1 residing at the
cell surface remain only modestly increased (20-40%) following Dyn2 knockdown. This minor
increase suggests that the massive increase in matrix degradation by the mesenchymal cells
following Dyn2 reduction may not be dependent upon an accumulation of active protease at
the cell surface.

siRNA

Invadopodia function is dependent upon Src kinase. To determine if the distinct matrix
degradation processes observed in the different cell types shared a requirement for Src
kinase, we treated cells with the Src inhibitor PP2. Cells were plated on gelatin in the presence
of the MMP inhibitor BB94 for 5 hours during plating to prevent degradation during attachment.
Subsequently cells were washed free of BB94 and incubated in 25mM PP2 for 13 hours. (a, e)
The pancreatic cancer lines DanG and BxPC3 both show robust degradation under control
conditions, but are almost completely inhibited when treated with 25mM PP2 (b, f). By contrast,
the fibrosarcoma cell line HT108 (c, d) and the Dyn2 knockout fibroblast cell line DKO (g, h)
both continue to degrade large amounts of matrix even under these high concentrations of
inhibitor. (i) A graph depicting the percentage of cells that degrade matrix upon Src inhibition.
Note the graphic contrast in drug sensitivity between the epithelial tumor cells and the
fibroblasts/fibroscarcoma cell lines.

• Reduction in Dyn2 levels results in a 2 fold increase of MT1-MMP with
a modest proportion of this protease remaining at the cell surface.

Conclusions
Stromal cells degrade matrix by a novel mechanism distinct from traditional
invadopodia.

